What is Eton Pharmaceuticals, Inc.'s investing cash flow?

Eton Pharmaceuticals, Inc. (ETON) reported investing cash flow of -$15.08M in Q1 2026.

What is the long-term trend for Eton Pharmaceuticals, Inc.'s investing cash flow?

Over 2 years (2022 to 2025), Eton Pharmaceuticals, Inc.'s investing cash flow has grown at a -65.4% compound annual growth rate (CAGR), from -$2.79M to -$333K.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Eton Pharmaceuticals, Inc. ETON Investing Cash Flow

Investing Cash Flow at other companies

HRO

HarrowHROW

-$18.2M-8,486%

Zevra Therapeutics, Inc.ZVRA

$79.62M+655%

XER

Xeris Biopharma Holdings, Inc.XERS

-$325K-2,400%

Ultragenyx PharmaceuticalRARE

-$49M-141%

ANI PharmaceuticalsANIP

-$11.32M+42.9%

Crinetics PharmaceuticalsCRNX

-$252.36M-194%

Other financials

Income statement

See full

Revenue$24.3M+40.4%

Gross profit$14.7M+49.4%

Operating income$2.4M+614%

Net income$1.6M+199%

EPS (diluted)$0.05+183%

Balance sheet

See full

Cash & equivalents$19.7M+12.9%

Total debt$31.3M+3.7%

Total equity$30.6M+25.2%

Total assets$97.7M+16.3%

Cash flow

See full

Operating cash flow$7.4M+254%

CapEx$75.0K—

Free cash flow$7.3M+251%

Valuation

See full

Market cap$930.79M+156%

Enterprise value$942.39M+150%

P/S10.7×+3.2×

Profitability

See full

Gross margin54.8%-3.7pp

Operating margin-15.1%—

Net margin-9.5%-2.7pp

FCF margin17.1%—

Returns & leverage

See full

Return on equity-34.2%+0.9pp

Debt / equity1×-0.2×

Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s investing cash flow?: Eton Pharmaceuticals, Inc. (ETON) reported investing cash flow of -$15.08M in Q1 2026.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s investing cash flow?: Over 2 years (2022 to 2025), Eton Pharmaceuticals, Inc.'s investing cash flow has grown at a -65.4% compound annual growth rate (CAGR), from -$2.79M to -$333K.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.